Treatment group

Phys. salt control

Xylene control

One day after esfenvalerate

Two days after esfenvalerate

Seven days after esfenvalerate

Increase of early component [%]

45.9 ± 10.1

55.9 ± 15.3

29.9 ± 19.1

62.2 ± 12.9

53.8 ± 9.6

Increase of late component [%]

147.3 ± 51.1

494.9 ± 263.5

200 ± 86.1

101.6 ± 38.7

187.3 ± 106.7

No. of slices with ictal activity

4/8

4/8

3/8

3/7

2/8

Latency of first spontaneous activity [min]

18.58 ± 5.53

20.90 ± 5.27

26.36 ± 11.39

14.94 ± 5.39

16.77 ± 3.62

Latency of first ictal activity [min]

28.80 ± 6.08

44.96 ± 7.89

28.97 ± 14.05

20.13 ± 10.50

36.75 ± 4.15

No. of ictal episodes

2.88 ± 1.94

1.88 ± 1.55

2.43 ± 2.42

5.86 ± 5.59

0.88 ± 1.28

No. of interictal episodes

12.88 ± 11.70

17.25 ± 16.54

1.25 ± 1.06

53.60 ± 20.41

27.14 ± 12.50

Frequency of spontaneous episodes [1/min]

0.65 ± 0.12

0.96 ± 0.11

0.43 ± 0.03

2.30 ± 0.96

1.17 ± 0.37